Verisk Fraud Discovery Launched as CEO Sells Again
Verisk Analytics just launched its Fraud Discovery platform and reported its fourth consecutive EPS beat with guidance reaffirmed — yet CEO Lee Shavel has sold shares in July, August, and September, e
Verisk Fraud Discovery Launched as CEO Sells Again
NEW YORK, September 20 —
Verisk Analytics, Inc. (VRSK) beat earnings estimates for the fourth consecutive quarter and launched its Fraud Discovery platform in September, yet CEO Lee Shavel sold shares in July, August, and September, each time at a price above the $175.41 at which the stock now trades. The product story and the selling pattern cannot both be right.
- Q2 EPS of $1.98 beat consensus by 2.6%; full-year EPS guidance reaffirmed at $7.45, $7.75
- $2.55M in C-suite open-market sales over 90 days, zero purchases; CEO sold at $220.00 on earnings day
- Q3 faces two sequential headwinds: ILS margin benefit won't repeat; slow hurricane season pressures transactional revenue
Subscription Pricing Is the Operational Bull Case
Verisk Analytics provides data analytics exclusively to the insurance industry, including policy language, loss costs, catastrophe modeling, and property estimating through the Xactware suite. Q2 2026 revenue was $806 million, up 5.8% on an organic constant currency basis; subscriptions, 83% of total revenue, grew 8% organically through price realization and new logo additions. Underwriting segment revenue of $569 million grew 5.6% organically; Claims at $237 million grew 6.1%, led by anti-fraud analytics. CEO Shavel cited historical soft-market organic growth of 6.8%, arguing that carriers shifting toward data-driven underwriting discipline rely more heavily on Verisk's data sets. That thesis is worth stress-testing against today's price in the DCF calculator.
The Selling Doesn't Fit the Narrative
On July 29, earnings day, CEO Shavel sold 2,500 shares at $220.00, then exercised options and sold 3,535 shares at $196.94 on August 3 and 3,535 shares at $193.43 on September 1. CFO Elizabeth Mann sold 400 shares in each of July, August, and September at prices from $179.95 to $192.11. Total C-suite open-market sales over the 90-day window reached $2.55 million against zero purchases. VRSK now trades at $175.41, below every recorded sale price, including the CFO's August low of $179.95. Executives selling into a soft patch is common; selling at successively lower prices through the quarter is a different conversation.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| VRSK | $22.8B | 20.2x | -28.2% |
| CDW | $18.3B | 12.1x | -10.9% |
| ALLE | $12.9B | 15.6x | -14.4% |
| AME | $54.5B | 24.8x | +26.1% |
| ROP | $36.9B | 15.3x | -26.9% |
| MTD | $27.9B | 26.9x | +10.7% |
Q3 Is When the Guidance Gets Tested
Management reaffirmed full-year EPS guidance of $7.45, $7.75, but Q3 is structurally weaker. CFO Mann flagged that insurance-linked securities revenue boosting Q2 margins "will not repeat in the third quarter," while a slow hurricane season leaves transactional revenue exposed. EVP Saurabh Khemka noted commercial property clients are "not quoting as many of the opportunities that are out there." XactAI's 7,000 licensees and nearly 10-fold user growth since March, plus the September Fraud Discovery launch, are genuine product developments, but they are too early to offset a known margin compression quarter. If Q3 Adjusted EBITDA misses guidance pace, the subscription durability story starts requiring proof. Run the free Verisk Analytics, Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Verisk Analytics just launched its Fraud Discovery platform and reported its fourth consecutive EPS beat with guidance reaffirmed — yet CEO Lee Shavel has sold shares in July, August, and September, every time at a price above where the stock now trades at $175.41. The question is whether the product launches are the operative truth or the selling pattern is.